/주식/HYPR
HYPR

HYPR

Hyperfine Inc. Class A Common Stock

$0.741+0.000 (0.000%)

실시간 가격

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$0.741

고가

$0.741

저가

$0.741

거래량

0.46M

기업 기본 정보

거래 통계

AI 분석 리포트

마지막 업데이트: 2025년 5월 25일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

HYPR (Hyperfine Inc. Class A Common Stock): Decoding Recent Signals

Stock Symbol: HYPR Generate Date: 2025-05-25 00:51:07

Let's break down what's been happening with Hyperfine, a company known for its portable MRI system, the Swoop. We'll look at the latest news, how the stock price has moved, and what the AI is hinting at for the near future.

Recent News Buzz: A Mixed Bag

The news around Hyperfine lately gives us a bit of a mixed picture. On one hand, the company is stepping onto a bigger stage, participating in the Jefferies Global Healthcare Conference. That's usually a good sign, showing they're getting visibility and engaging with the investment community. Plus, they've announced their first-quarter 2025 financial results are coming out soon, which is standard procedure and keeps investors informed.

However, there's a noticeable shift from analysts. Both B. Riley Securities and Wells Fargo have maintained their ratings (Buy and Equal-Weight, respectively) but have lowered their price targets. B. Riley dropped theirs from $1.20 to $1.00, and Wells Fargo cut theirs even more sharply, from $1.29 to $0.68. This suggests that while analysts still see some potential, they're becoming more cautious about the stock's immediate upside. Lowering price targets often signals concerns about future growth or profitability, or perhaps a re-evaluation of market conditions.

Price Check: A Rocky Ride Down

Looking at the last 30 days of trading, HYPR has been on a clear downward trend. Back in late February, it was hovering around the $1.00 mark. There was a massive spike in mid-March, hitting $1.36 on huge volume, but that was quickly followed by a sharp drop. Since then, the price has generally drifted lower, moving from the $0.80s in late March down to the $0.50s by late May.

The stock closed recently at $0.5779. This is quite a bit lower than where it was a couple of months ago, and it's also very close to its 52-week low of $0.5327. The trading volume has been inconsistent, with some days seeing higher activity, especially during the sharp declines.

Now, here's where it gets interesting: the AI prediction for today is a modest gain of 0.95%, followed by 1.55% tomorrow and 2.88% the day after. If these predictions hold, it would mean a slight upward bounce from the recent lows.

Outlook & Ideas: A Cautious Glimmer?

Putting it all together, the situation for HYPR seems to be at a crossroads. The analyst downgrades on price targets are a definite negative signal, reflecting some underlying concerns. The historical price action confirms this bearish sentiment, with the stock consistently losing ground.

However, the AI model from AIPredictStock.com offers a different perspective, forecasting small but consistent positive price movements over the next few days. This could suggest that the stock is nearing a bottom or is due for a short-term rebound after its recent declines. The recommendation data also points to a "Bullish Momentum" and "Undervalued Gem" with a "Buy" rating from analysts and an average price target of $0.98, which is significantly higher than the current price. The technical indicators are mixed, with a bearish DMI but a bullish MACD crossover and the price being very close to a support level.

Given the current price is around $0.58, and the 52-week low is $0.5327, the stock is trading in a very low range. The AI's prediction of an upward trend, combined with the "Undervalued Gem" tag and the technical signal that the price is near a strong support level ($0.54), might suggest a potential entry point for those comfortable with higher risk.

Potential Entry Consideration: If you're considering a move, a price around the current level, perhaps a slight dip towards $0.54 or $0.53, could be an area to watch. This aligns with the identified support level and the AI's short-term positive outlook.

Potential Exit/Stop-Loss Consideration: For managing risk, a stop-loss order placed just below the 52-week low, say around $0.49, would be a sensible move. This helps limit potential losses if the downward trend continues. On the upside, if the AI's predictions play out, a take-profit target around $0.60 or even $0.65 could be considered, especially if the stock shows signs of breaking above recent resistance. The recommendation data suggests a take-profit at $0.55, which is a very short-term target. The AI also projects a potential target price of $1.03, which aligns with the analyst average target.

Company Context: Medical Devices in Focus

It's important to remember that Hyperfine operates in the Medical Devices sector, specifically with its portable MRI system, the Swoop. This is a specialized field, and the company's success hinges on the adoption and continued innovation of its technology. News about clinical trials, regulatory approvals, or sales figures for the Swoop system would be particularly impactful. The upcoming financial results announcement will be key to understanding their operational health and future prospects. The company's relatively small market capitalization ($42.4 million) and employee count (111) mean it can be more volatile than larger, more established firms.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in stocks carries inherent risks, and past performance is not indicative of future results. Always conduct your own thorough research and consult with a qualified financial professional before making any investment decisions.

관련 뉴스

BusinessWire

Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality

This major Swoop® system scanner redesign and Optive AI™ software elevate the AI-powered portable MRI experience for clinicians and their patients across multiple sites of care. Hyperfine, Inc.

더 보기
Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality
BusinessWire

Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop®

더 보기
Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference
Analyst Upgrades

B. Riley Securities Maintains Buy on Hyperfine, Lowers Price Target to $1

B. Riley Securities analyst Yuan Zhi maintains Hyperfine with a Buy and lowers the price target from $1.2 to $1.

더 보기
B. Riley Securities Maintains Buy on Hyperfine, Lowers Price Target to $1
Analyst Upgrades

Wells Fargo Maintains Equal-Weight on Hyperfine, Lowers Price Target to $0.68

Wells Fargo analyst Larry Biegelsen maintains Hyperfine with a Equal-Weight and lowers the price target from $1.29 to $0.68.

더 보기
Wells Fargo Maintains Equal-Weight on Hyperfine, Lowers Price Target to $0.68

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 6월 12일 오후 10:31

약세중립강세

61.0% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
가치
트레이딩 가이드

진입점

$0.82

익절

$0.85

손절

$0.74

핵심 요소

DMI는 약세 추세(ADX:10.3, +DI:24.1, -DI:30.1)를 보여 주의를 요합니다.
현재 가격이 지지선($0.83)에 매우 근접하여 강력한 매수 기회를 시사합니다.
MACD -0.0047이(가) 신호선 -0.0036 아래에 있어 약세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기